Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (2309)
All Articles published online
|
Jul 14, 2006 (publication date) through Aug 25, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Leelawat K, Leelawat S, Ratanachu-Ek T, Trubwongchareon S, Wannaprasert J, Tripongkaruna S, Chantawibul S, Tepaksorn P. Circulating hTERT mRNA as a tumor marker in cholangiocarcinoma patients. World J Gastroenterol 2006; 12(26): 4195-4198 [PMID: 16830373 DOI: 10.3748/wjg.v12.i26.4195] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v12/i26/4195.htm |
| Number | Citing Articles |
| 1 |
Marcus Wiedmann, Helmut Witzigmann, Joachim Mössner. Clinical Hepatology. 2010; : 1519 doi: 10.1007/978-3-642-04519-6_62
|
| 2 |
Peter Arenberger, Monika Arenbergerova, Olga Vohradnikova, Jaromir Kremen. Early Detection of Melanoma Progression by Quantitative Real-time RT-PCR Analysis for Multiple Melanoma Markers. The Keio Journal of Medicine 2008; 57(1): 57 doi: 10.2302/kjm.57.57
|
| 3 |
P Arenberger, M Arenbergerova, S Gkalpakiotis, J Lippert, J Stribrna, J Kremen. Multimarker real‐time reverse transcription‐PCR for quantitative detection of melanoma‐associated antigens: a novel possible staging method. Journal of the European Academy of Dermatology and Venereology 2008; 22(1): 56 doi: 10.1111/j.1468-3083.2007.02329.x
|
| 4 |
M. Grunnet, M. Mau-Sørensen. Serum tumor markers in bile duct cancer – a review. Biomarkers 2014; 19(6): 437 doi: 10.3109/1354750X.2014.923048
|
| 5 |
J. Y. H. Chan, K. K. H. Lee, Y. L. Chui. Hilar Cholangiocarcinoma. 2013; : 111 doi: 10.1007/978-94-007-6473-6_10
|
| 6 |
Atsushi Nanashima, Takafumi Abo, Goushi Murakami, Aya Matsumoto, Kazuo Tou, Hiroaki Takeshita, Masaki Kunizaki, Shigekazu Hidaka, Ichiro Sakamoto, Hideyuki Hayashi, Toru Fukuda, Takashi Kudo, Takeshi Nagayasu. Intrahepatic cholangiocarcinoma: relationship between tumor imaging enhancement by measuring attenuation and clinicopathologic characteristics. Abdominal Imaging 2013; 38(4): 785 doi: 10.1007/s00261-012-9974-3
|
| 7 |
Masoumeh Mehrpouya, Zeinab Pourhashem, Najmeh Yardehnavi, Morteza Oladnabi. Evaluation of cytokeratin 19 as a prognostic tumoral and metastatic marker with focus on improved detection methods. Journal of Cellular Physiology 2019; 234(12): 21425 doi: 10.1002/jcp.28768
|
| 8 |
Li Xie, Tingting Wang, Shaorong Yu, Xi Chen, Lifeng Wang, Xiaoping Qian, Lixia Yu, Yitao Ding, Chenyu Zhang, Baorui Liu. Cell-free miR-24 and miR-30d, potential diagnostic biomarkers in malignant effusions. Clinical Biochemistry 2011; 44(2-3): 216 doi: 10.1016/j.clinbiochem.2010.11.002
|
| 9 |
Tushar Patel, Pankaj Singh. Cholangiocarcinoma: emerging approaches to a challenging cancer. Current Opinion in Gastroenterology 2007; 23(3): 317 doi: 10.1097/MOG.0b013e3280495451
|
| 10 |
Florian Eckel, Roland M Schmid. Emerging drugs for biliary cancer. Expert Opinion on Emerging Drugs 2007; 12(4): 571 doi: 10.1517/14728214.12.4.571
|
| 11 |
Hiroaki Haga, Tushar Patel. Molecular diagnosis of intrahepatic cholangiocarcinoma. Journal of Hepato-Biliary-Pancreatic Sciences 2015; 22(2): 114 doi: 10.1002/jhbp.156
|
| 12 |
Watcharin Loilome, Nisana Namwat, Apinya Jusakul, Anchalee Techasen, Poramate Klanrit, Jutarop Phetcharaburanin, Arporn Wangwiwatsin. Liver Fluke, Opisthorchis viverrini Related Cholangiocarcinoma. Recent Results in Cancer Research 2023; 219: 53 doi: 10.1007/978-3-031-35166-2_4
|